DNLI · Categories · Form 3

DNLI - SEC Form 3 initial insider statements

Denali Therapeutics Inc. (DNLI) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for DNLI

• 48d
  Amendment: SEC Form 3 filed by new insider Chin Peter Scott

  3/A - Denali Therapeutics Inc. (0001714899) (Issuer)
• 49d
  SEC Form 3 filed by new insider Chin Peter Scott

  3 - Denali Therapeutics Inc. (0001714899) (Issuer)
• 214d
  SEC Form 3 filed by new insider Van Hauwermeiren Timothy

  3 - Denali Therapeutics Inc. (0001714899) (Issuer)
• 368d
  New insider Baker Bros. Advisors Lp claimed ownership of 3,731,695 shares (SEC Form 3)

  3 - Denali Therapeutics Inc. (0001714899) (Issuer)
• 368d
  SEC Form 3 filed by new insider Baker Julian

  3 - Denali Therapeutics Inc. (0001714899) (Issuer)
• 1575d
  SEC Form 3 filed by new insider Harris Erik (Amendment)

  3/A - Denali Therapeutics Inc. (0001714899) (Issuer)
• 1582d
  SEC Form 3 filed by new insider Harris Erik

  3 - Denali Therapeutics Inc. (0001714899) (Issuer)

Other DNLI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends